| The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome JM Engreitz, A Pandya-Jones, P McDonel, A Shishkin, K Sirokman, ... Science 341 (6147), 1237973, 2013 | 1098 | 2013 |
| Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells ML Suvà, E Rheinbay, SM Gillespie, AP Patel, H Wakimoto, SD Rabkin, ... Cell 157 (3), 580-594, 2014 | 923 | 2014 |
| Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis SP Pitroda, NN Khodarev, L Huang, A Uppal, SC Wightman, S Ganai, ... Nature communications 9 (1), 1793, 2018 | 229 | 2018 |
| Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma V Panou, M Gadiraju, A Wolin, CM Weipert, E Skarda, AN Husain, ... Journal of Clinical Oncology 36 (28), 2863-2871, 2018 | 202 | 2018 |
| Evolutionary analysis across mammals reveals distinct classes of long non-coding RNAs J Chen, AA Shishkin, X Zhu, S Kadri, I Maza, M Guttman, JH Hanna, ... Genome biology 17, 1-17, 2016 | 153 | 2016 |
| Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL S Kadri, J Lee, C Fitzpatrick, N Galanina, M Sukhanova, G Venkataraman, ... Blood advances 1 (12), 715-727, 2017 | 125 | 2017 |
| HHMMiR: efficient de novo prediction of microRNAs using hierarchical hidden Markov models S Kadri, V Hinman, PV Benos BMC bioinformatics 10, 1-12, 2009 | 124 | 2009 |
| Autophagy inhibition to augment mTOR inhibition: a phase I/II trial of everolimus and hydroxychloroquine in patients with previously treated renal cell carcinoma NB Haas, LJ Appleman, M Stein, M Redlinger, M Wilks, X Xu, A Onorati, ... Clinical cancer research 25 (7), 2080-2087, 2019 | 117 | 2019 |
| Clinical validation of a next-generation sequencing genomic oncology panel via cross-platform benchmarking against established amplicon sequencing assays S Kadri, BC Long, I Mujacic, CJ Zhen, MN Wurst, S Sharma, N McDonald, ... The Journal of Molecular Diagnostics 19 (1), 43-56, 2017 | 116 | 2017 |
| Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies MW Drazer, S Kadri, M Sukhanova, SA Patil, AH West, S Feurstein, ... Blood advances 2 (2), 146-150, 2018 | 109 | 2018 |
| Unified classification of mouse retinal ganglion cells using function, morphology, and gene expression J Goetz, ZF Jessen, A Jacobi, A Mani, S Cooler, D Greer, S Kadri, J Segal, ... Cell reports 40 (2), 2022 | 96 | 2022 |
| Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL S Sharma, N Galanina, A Guo, J Lee, S Kadri, C Van Slambrouck, B Long, ... Oncotarget 7 (42), 68833, 2016 | 83 | 2016 |
| A negative feedback loop of transcription factors specifies alternative dendritic cell chromatin States C Bornstein, D Winter, Z Barnett-Itzhaki, E David, S Kadri, M Garber, I Amit Molecular cell 56 (6), 749-762, 2014 | 71 | 2014 |
| Are sporadic eosinophilic solid and cystic renal cell carcinomas characterized by somatic tuberous sclerosis gene mutations? M Parilla, S Kadri, SA Patil, L Ritterhouse, J Segal, KJ Henriksen, T Antic The American journal of surgical pathology 42 (7), 911-917, 2018 | 61 | 2018 |
| B-cell lymphoma patient-derived xenograft models enable drug discovery and are a platform for personalized therapy L Zhang, K Nomie, H Zhang, T Bell, L Pham, S Kadri, J Segal, S Li, ... Clinical Cancer Research 23 (15), 4212-4223, 2017 | 55 | 2017 |
| Noninvasive follicular thyroid neoplasms with papillary-like nuclear features are genetically and biologically similar to adenomatous nodules and distinct from papillary … DN Johnson, LV Furtado, BC Long, CJ Zhen, M Wurst, I Mujacic, S Kadri, ... Archives of pathology & laboratory medicine 142 (7), 838-850, 2018 | 44 | 2018 |
| XPO1 inhibitor selinexor overcomes intrinsic ibrutinib resistance in mantle cell lymphoma via nuclear retention of IκB M Ming, W Wu, B Xie, M Sukhanova, W Wang, S Kadri, S Sharma, J Lee, ... Molecular cancer therapeutics 17 (12), 2564-2574, 2018 | 39 | 2018 |
| Genetic underpinnings of renal cell carcinoma with leiomyomatous stroma M Parilla, M Alikhan, M Al-Kawaaz, S Patil, S Kadri, LL Ritterhouse, ... The American journal of surgical pathology 43 (8), 1135-1144, 2019 | 38 | 2019 |
| Cerdulatinib pharmacodynamics and relationships to tumor response following oral dosing in patients with relapsed/refractory B-cell malignancies GP Coffey, J Feng, A Betz, A Pandey, M Birrell, JM Leeds, K Der, S Kadri, ... Clinical Cancer Research 25 (4), 1174-1184, 2019 | 33 | 2019 |
| RNA deep sequencing reveals differential microRNA expression during development of sea urchin and sea star S Kadri, VF Hinman, PV Benos PLoS one 6 (12), e29217, 2011 | 32 | 2011 |
